Literature DB >> 17178694

Histological investigation of diagnostically challenging tubule profiles in advanced chronic progressive nephropathy (CPN) in the fischer 344 RaT.

Gordon C Hard1, John Curtis Seely.   

Abstract

Recently, guidelines were suggested for discriminating proliferative-appearing tubule profiles encountered in advanced spontaneous chronic progressive nephropathy (CPN) of rats, from hyperplastic precursors of renal tubule tumors (Hard and Seely, 2005). These recommendations were based on histological evaluation of a large number of cases of severe to end-stage CPN in male F344 rats from 8 separate 2-year carcinogenicity studies held in the Archives of the National Toxicology Program, NIEHS. This work has now been extended to characterize the various lesions further, mainly by serial sectioning to track their origin and fate within the adjacent renal tissue, but also by applying special staining procedures such as immunohistochemical assessment of proliferative activity, as well as fluorescence microscopy, to seek further differences from atypical tubule hyperplasia. The results obtained from these additional investigations support the contention that certain tubule profiles with a misleading proliferative appearance, sometimes found in advanced CPN, should be distinguished from preneoplastic tubule foci, and regarded as components of the nephropathy process.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17178694     DOI: 10.1080/01926230601083381

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  2 in total

Review 1.  Confounders for kidney carcinogenesis in rodent cancer bioassays.

Authors:  Gordon C Hard
Journal:  J Toxicol Pathol       Date:  2021-10-14       Impact factor: 1.628

2.  Consideration of rat chronic progressive nephropathy in regulatory evaluations for carcinogenicity.

Authors:  Gordon C Hard; Marcy I Banton; Robert S Bretzlaff; Wolfgang Dekant; Jefferson R Fowles; Anthony K Mallett; Douglas B McGregor; Kathleen M Roberts; Robert L Sielken; Ciriaco Valdez-Flores; Samuel M Cohen
Journal:  Toxicol Sci       Date:  2012-10-26       Impact factor: 4.849

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.